O’Melveny & Myers LLP acted as legal advisor for Tantti Laboratory Inc. LCS & Partners acted as legal advisor for Tantti Laboratory Inc. EC M&A acted...
Repligen Corporation’s Acquisition of Tantti Laboratory
Adlai Nortye’s US$100 Million Initial Public Offering
O’Melveny represented Adlai Nortye Ltd. in the transaction. Adlai Nortye Ltd. (NASDAQ: ANL) announced its IPO on the Nasdaq. Adlai Nortye expects to receive aggregate gross...
OrbusNeich Medical Group’s US$61.6 Million Initial Public Offering
Baker McKenzie advised the underwriters on the deal while O’Melveny represented OrbusNeich Medical Group. OrbusNeich Medical Group Holdings Limited (6929.HK) announced its approximate US$61.6 million (approximately HK$481...
Huafang Group Inc.’s IPO
O’Melveny advised the sponsors and underwriters on the listing, while Wilson Sonsini Goodrich & Rosati and Maples and Calder represented Huafang. Huafang Group Inc. announced the IPO...
C&D International’s US$64 Million Top-up Share Placement and Subscription
O’Melveny represented China International Capital Corporation Hong Kong Securities Limited (CICC) and China Industrial Securities International Capital Limited on the deal. China International Capital Corporation Hong...
Belite Bio’s $36 Million IPO
Wilson Sonsini Goodrich & Rosati and O’Melveny advised Belite Bio on the deal. Belite Bio, Inc., a clinical-stage biopharmaceutical drug development company, announced the pricing of...
Central China Management’s Spin-off and Listing
O’Melveny & Myers LLP advised BNP Paribas, China Construction Bank International, Industrial and Commercial Bank of China International and other underwriters on the deal. Conyers provided...